You are here

Home › Listings › Life Sciences › Predictmedix AI Inc.

Predictmedix AI Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
PMED
CSE Index: 
Currency: 

Predictmedix AI Inc. is an artificial intelligence ("AI") company developing disruptive and cutting-edge tools for impairment testing and healthcare testing. The Issuer's proprietary technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. The Issuer is also developing cutting edge screening technologies for the healthcare industry.  Predictmedix is expanding its proprietary AI technology to screen for infectious diseases, and also to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer’s disease. 

You are here

Home

Predictmedix AI Inc. (PMED)

SEDAR Information

Search form

Company Info

Address
3000 - 77 King Street West
Toronto, ON M5K 1G8
Canada
Phone
647 889-6916
Email
[email protected]
Website
https://www.predictmedix.com
Listing date
Friday, December 20, 2019
Transfer Agent
National Securities Administrators Ltd.
Email
[email protected]
Auditor
Kreston GTA LLP

Capitalization

Issued & Outstanding: 
150,259,542
Reserved for Issuance: 
31,217,150

News Releases

13/07/2023

Predictmedix Inc. Announces Name Change to Predictmedix AI Inc.

31/03/2023

Predictmedix’s Safe Entry Receives International Recognition in Major Indonesian Newspaper for its Healthcare Application

Bulletins

14/07/2023

2023-0719 - Name Change - Predictmedix Inc. (PMED)

le 14 juillet/July 2023

Predictmedix Inc. has announced a name change to Predictmedix AI Inc.

Shares will begin trading under the new name and with a new CUSIP number on July 17, 2023.

CSE Filings

Form 9 - Notice of Issuance of Listed Securities (November 2023)

Form 9 - Notice of Issuance of Listed Securities

Form 7 - Monthly Progress Report (October 2023)

Form 9 - Notice of Issuance of Listed Securities (November 2 2023)

Form 7 - Monthly Progress Report (September 2023)